tirzepatide canada brand name FDA Grants a New Indication for Obesity Management Users of Zepbound or Mounjaro
Description
Market Segmentation Indication Insights (Revenue, USD Bn, 2021 - 2033) Type 2 Diabetes Chronic Weight Management Obstructive Sleep Apnea (OSA) Dosage Form Insights (Revenue, USD Bn, 2021 - 2033) Single-dose Pen Single-dose Vial Strength Insights (Revenue, USD Bn, 2021 - 2033) 5 mg 5 mg 5 mg 10 mg 5 mg 15 mg Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies End User Insights (Revenue, USD Bn, 2021 - 2033) Hospitals Specialty Clinics Outpatient & Primary Care Centers Long-Term Care Facilities Others (Research & Academic Institutions, etc.) Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S

4 September 2024

Do not administer two injections within 3 days of each other

We find that this advanced approach is particularly effective for those who have hit weight plateaus or require more intensive metabolic correction
Some compounding pharmacies prefer this strength because it keeps every dose through 15mg within a single injection

Compared to other GLP-1 receptor agonists like Ozempic and Trulicity which are slightly cheaper but may not have the same weight loss results
